Esperion is a pharmaceutical company that specializes in developing and commercializing oral therapies for the treatment of patients with elevated LDL-C. read more

EMPLOYEE PARTICIPANTS: 19

TOTAL RATINGS: 316

CEO: Timothy Mayleben

HR or Marketing? Claim Your Free Employer Account

Timothy Mayleben Esperion Therapeutics CEO Rating

Esperion Therapeutics' CEO, Timothy Mayleben, has 16 employee ratings and a score of 21/100, placing them in the Bottom 5% of similar size companies on Comparably with 51-200 Employees.

Last updated months ago.

Where This Score Ranks Esperion Therapeutics' CEO Rating

BOTTOM
5%
In the Bottom 5% of 2035 Similar Sized Companies on Comparably
2nd
2nd place versus 2 competitors rated on Comparably

Aug

Dec

Jun

Sep

Feb

F21 / 100

Jan

Esperion Therapeutics CEO Timothy Mayleben Bio

Timothy Mayleben serves as the CEO / President of Esperion Therapeutics.

Who Ranks Esperion Therapeutics' CEO Rating the Highest?

Ethnicity - Caucasian 24/100

Tenure - 1 to 2 Years 24/100

Gender - Female 23/100

Who Ranks Esperion Therapeutics' CEO Rating the Lowest?

Experience - Over 10 Years 15/100

Esperion Therapeutics CEO Timothy Mayleben At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Esperion Therapeutics.

Based on 16 ratings, Timothy Mayleben ranks right below Biogen's CEO, Michel Vounatsos.

Esperion Therapeutics' CEO is highly regarded by Caucasian employees, employees who have been at the company 1 to 2 Years, and Female employees. However, employees with Over 10 Years experience have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.